CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schlegel, R.
Right arrow Articles by Harris, M. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schlegel, R.
Right arrow Articles by Harris, M. O.

Cell Growth & Differentiation, Vol 1, Issue 4 171-178, Copyright © 1990 by American Association of Cancer Research


ARTICLES

Premature mitosis induced in mammalian cells by the protein kinase inhibitors 2-aminopurine and 6-dimethylaminopurine

R Schlegel, GS Belinsky and MO Harris
Charles A. Dana Laboratory of Toxicology, Harvard School of Public Health, Boston, Massachusetts 02115.

The protein kinase inhibitors 2-aminopurine (2-AP) and 6-dimethylaminopurine (6-DMAP) were used to examine the effects of protein dephosphorylation on the control of mitosis in mammalian cells. Both 2-AP and 6-DMAP induced premature mitosis in hamster fibroblasts that were arrested in S phase. This response was characterized by changes in cell morphology, breakdown of the nuclear envelope, and premature chromosome condensation. Premature mitosis was followed by a return to interphase morphology and reformation of the nuclear envelope around decondensed and fragmented chromatin to form numerous micronuclei. The activity of both compounds was dependent upon new protein synthesis but not new RNA synthesis. 2-AP and 6-DMAP acted cooperatively with each other and with caffeine, suggesting a common mechanism of action. In exponentially growing cells, 2-AP and 6-DMAP did not induce premature mitosis but did increase the frequency of binucleated cells by blocking cytokinesis. These findings support a role for protein dephosphorylation in the control of mitosis and indicate that cell cycle perturbations can modify this regulation.


This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
M. A. Shah and G. K. Schwartz
Cell Cycle-mediated Drug Resistance: An Emerging Concept in Cancer Therapy
Clin. Cancer Res., August 1, 2001; 7(8): 2168 - 2181.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
P. De Cesaris, D. Starace, G. Starace, A. Filippini, M. Stefanini, and E. Ziparo
Activation of Jun N-terminal Kinase/Stress-activated Protein Kinase Pathway by Tumor Necrosis Factor {alpha} Leads to Intercellular Adhesion Molecule-1 Expression
J. Biol. Chem., October 8, 1999; 274(41): 28978 - 28982.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
M. W. Marino, J. D. Dunbar, L.-W. Wu, J. R. Ngaiza, H.-M. Han, D. Guo, M. Matsushita, A. C. Nairn, Y. Zhang, R. Kolesnick, et al.
Inhibition of Tumor Necrosis Factor Signal Transduction in Endothelial Cells by Dimethylaminopurine
J. Biol. Chem., November 8, 1996; 271(45): 28624 - 28629.
[Abstract] [Full Text] [PDF]


Home page
Cold Spring Harb Symp Quant BiolHome page
A.W. Murray
Coordinating Cell Cycle Events
Cold Spring Harb Symp Quant Biol, January 1, 1991; 56(0): 399 - 408.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1990 by the American Association of Cancer Research.